Serum levels of vascular endothelial growth factor and basic fibroblastic growth factor as predictors of disease-progression in early B-cell chronic lymphocytic leukemia.

被引：0
|
作者：
Molica, S
Vitelli, G
Levato, D
Ricciotti, A
Gandolfo, GM
机构：
[1] Azienda Osped Pugliese Ciaccio, Catanzaro, Italy
[2] Ist Regina Elena, IRCCS, I-00161 Rome, Italy
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1594
引用
收藏
页码：369A / 369A
页数：1
相关论文
共 50 条
  • [1] Clinicoprognostic implications of increased serum levels of vascular endothelial growth factor and basic fibroblastic growth factor in early B-cell chronic lymphocytic leukaemia
    S Molica
    G Vitelli
    D Levato
    A Ricciotti
    G Digiesi
    British Journal of Cancer, 2002, 86 : 31 - 35
  • [2] Clinicoprognostic implications of increased serum levels of vascular endothelial growth factor and basic fibroblastic growth factor in early B-cell chronic lymphocytic leukaemia
    Molica, S
    Vitelli, G
    Levato, D
    Ricciotti, A
    Digiesi, G
    BRITISH JOURNAL OF CANCER, 2002, 86 (01) : 31 - 35
  • [3] Plasma levels of vascular endothelial growth factor (VEGF) are predictive of disease-progression in B-cell chronic lymphocytic leukemia (B-CLL).
    Maurillo, L
    Del Poeta, G
    Venditti, A
    Giovanna, S
    Buccisano, F
    Del Principe, MI
    Tamburini, A
    Scornajenghi, A
    Epiceno, AM
    Piccioni, D
    Amadori, S
    BLOOD, 2001, 98 (11) : 360A - 360A
  • [4] Serum insulinlike growth factor is not elevated in patients with early B-cell chronic lymphocytic leukemia but is still a prognostic factor for disease-progression
    Molica, S
    Vitelli, G
    Giannarelli, D
    Mirabelli, R
    ANNALS OF ONCOLOGY, 2005, 16 : 202 - 203
  • [5] Clinico-prognostic implications of increased levels of serum vascular endothelial growth factor in B-cell chronic lymphocytic leukemia.
    Molica, S
    Vitelli, G
    Levato, D
    Gandolfo, GM
    Liso, V
    BLOOD, 1998, 92 (10) : 100A - 100A
  • [6] Increased serum levels of vascular endothelial growth factor predict risk of progression in early B-cell chronic lymphocytic leukaemia
    Molica, S
    Vitelli, G
    Levato, D
    Gandolfo, GM
    Liso, V
    BRITISH JOURNAL OF HAEMATOLOGY, 1999, 107 (03) : 605 - 610
  • [7] Clinical relevance of intracellular vascular endothelial growth factor levels in B-cell chronic lymphocytic leukemia
    Aguayo, A
    O'Brien, S
    Keating, M
    Manshouri, T
    Gidel, C
    Barlogie, B
    Beran, M
    Koller, C
    Kantarjian, H
    Albitar, M
    BLOOD, 2000, 96 (02) : 768 - 770
  • [8] Plasma levels of basic fibroblast growth factor and vascular endothelial growth factor and their association with IgVH mutation status in patients with B-cell chronic lymphocytic leukemia
    Smolej, Lukas
    Andrys, Ctirad
    Pekova, Sona
    Schwarz, Jiri
    Belada, David
    Zak, Pavel
    HAEMATOLOGICA, 2006, 91 (10) : 1432 - 1433
  • [9] Serum insulinlike growth factor is not elevated in patients with early B-cell chronic lymphocytic leukemia but is still a prognostic factor for disease-progression.
    Molica, S
    Vitelli, G
    Mirabelli, R
    Digiesu, G
    Giannarelli, D
    Iorfida, A
    BLOOD, 2004, 104 (11) : 279B - 280B
  • [10] VASCULAR ENDOTHELIAL GROWTH FACTOR PLAYS AN IMPORTANT ROLE IN CHRONIC MYELOGENOUS LEUKEMIA: RELATIONSHIP TO DISEASE-PROGRESSION
    Shirasaki, R.
    Tashiro, H.
    Noguchi, M.
    Sugao, T.
    Oka, Y.
    Kawasugi, K.
    Akiyama, Y.
    Shirafuji, N.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 538 - 539
12345